Kidney-Targeted Nanoparticle Delivery of Formoterol Mitigates Diabetic Kidney Disease without Adverse Cardiac Effects. [PDF]
Vallorz EL +5 more
europepmc +1 more source
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal
A. P. Greening +9 more
core +1 more source
Assessing the impact of GINA guideline-Concordant medication prescribing on asthma outcomes in a tertiary hospital in Saudi Arabia: a retrospective cohort study. [PDF]
Alamer A +7 more
europepmc +1 more source
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study. [PDF]
Cherian M, Dell'Aniello S, Suissa S.
europepmc +1 more source
The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases
Hulya Bayiz,1 Sevket Ozkaya,1 Adem Dirican,2 Ferah Ece1 1Department of Pulmonary Medicine, Faculty of Medicine, Bahcesehir University, Istanbul, 2Department of Pulmonary Medicine, Samsun Medical Park Hospital, Samsun, TurkeyIntroduction: The use of ...
Ozkaya S, Ece F, Dirican A, Bayiz H
core
Safety analysis of long-acting dual bronchodilator after market approval: a real-world study from FDA Adverse Event Reporting System (FAERS) database. [PDF]
Gao S +8 more
europepmc +1 more source
The effect of formoterol over 24h in patients with asthma: the role of enantiomers
The single-dose effect of formoterol racemate and enantiomers on bronchodilatation up to 24h was determined. Forty-six reversible asthmatic patients were randomised to this double blind, crossover study. Formoterol was inhaled by nebulizer (HaloLite((R)))
Lötvall, Jan, +9 more
core
As-needed inhaled corticosteroids in asthma: from evidence to implementation. [PDF]
Merrell E, Khurana S.
europepmc +1 more source
The β<sub>2</sub>-adrenoceptor agonist formoterol attenuates hallmarks of adrenal Cushing's syndrome. [PDF]
Cleveland KH +7 more
europepmc +1 more source
Therapeutic potential of synergistic mucociliary clearance for cystic fibrosis airways by β-adrenergic plus cholinergic agonists. [PDF]
Joo NS +12 more
europepmc +1 more source

